Patients who experienced eight or more partial-onset seizures , whether or not secondarily generalized , during the 8-week prospective baseline period were randomized ( 1:1:1:1 ) to receive twice-daily placebo ( PBO ) or BRV ( 5 , 20 , or 50 mg/day ) without titration .